Literature DB >> 16724512

Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonist.

D Jeremy Stewart1, Hesham Fahmy, Bryan L Roth, Feng Yan, Jordan K Zjawiony.   

Abstract

Salvinorin A ((2S,4aR,6aR,7R,9S,10aS, 10bR)-2H-naphtho[2,1-c]pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo methyl ester, 1, CAS 83729-01-5) has been shown to bind with high affinity and selectivity to the kappa-opioid receptor (KOR) as an agonist. Bioisosteres of 1 were developed and biologically evaluated in binding and functional assays. The C-2 thioacetate isoster produced comparable activity to 1, but nitrogen substitution had a diminishing effect. Intermediates, which lack a beta-carbonyl at C-2, displayed moderate affinity. The derivatives were tested against all opioid subtypes and were selective towards KOR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724512     DOI: 10.1055/s-0031-1296720

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  11 in total

Review 1.  Clerodane diterpenes: sources, structures, and biological activities.

Authors:  Rongtao Li; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2016-07-18       Impact factor: 13.423

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 3.  Salvinorin A analogs as probes in opioid pharmacology.

Authors:  Thomas E Prisinzano; Richard B Rothman
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

Review 4.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

5.  Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids.

Authors:  Jakub Fichna; Kevin Lewellyn; Feng Yan; Bryan L Roth; Jordan K Zjawiony
Journal:  Bioorg Med Chem Lett       Date:  2010-11-11       Impact factor: 2.823

6.  Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.

Authors:  Ruslan V Bikbulatov; Feng Yan; Bryan L Roth; Jordan K Zjawiony
Journal:  Bioorg Med Chem Lett       Date:  2007-02-02       Impact factor: 2.823

7.  Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.

Authors:  Prabhakar R Polepally; Kate White; Eyal Vardy; Bryan L Roth; Daneel Ferreira; Jordan K Zjawiony
Journal:  Bioorg Med Chem Lett       Date:  2013-04-04       Impact factor: 2.823

8.  CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity.

Authors:  Donna L McGovern; Philip D Mosier; Bryan L Roth; Richard B Westkaemper
Journal:  J Mol Graph Model       Date:  2010-01-04       Impact factor: 2.518

9.  Herkinorin analogues with differential beta-arrestin-2 interactions.

Authors:  Kevin Tidgewell; Chad E Groer; Wayne W Harding; Anthony Lozama; Matthew Schmidt; Alfred Marquam; Jessica Hiemstra; John S Partilla; Christina M Dersch; Richard B Rothman; Laura M Bohn; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2008-04-02       Impact factor: 7.446

10.  Unusual hemiacetal structure derived from Salvinorin A.

Authors:  Paulo Carvalho; Ruslan Bikbulatov; Jordan K Zjawiony; Mitchell A Avery
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.